QNB Group Chief Business Officer Yousef Mahmoud Al Neama along with other officials during the PMFG 2024 Summit.
Doha: QNB announced its role as a Diamond Sponsor of the Precision Medicine and Future of Genomics PMFG 2024 Summit, hosted by Sidra Medicine.
QNB’s sponsorship underscores the bank’s dedication to fostering collaboration between frontline clinicians, pharmacists, clinician-scientists, and translational researchers.
The summit will serve as a platform to explore cutting-edge genomic medicine solutions aimed at enhancing patient care and outcomes.
The event, themed “Personalized Genomic Medicine and Next-Generation Therapies,” is set to unite medical professionals in advancing the future of personalized healthcare.
Commenting on the partnership, Yousef Mahmoud Al Neama, QNB Group Chief Business Officer said: “ We are honored to support such a transformative event. At QNB, we believe that progress in healthcare innovation is key to building a healthier and more sustainable future. This summit aligns with our commitment to empowering communities and advancing knowledge in critical fields such as precision medicine.”
The summit will feature esteemed speakers, panel discussions, and workshops that address the latest breakthroughs in genomic research and next-generation therapies.
By bringing together global experts and regional stakeholders, Sidra Medicine aims to create a collaborative environment for developing cutting-edge healthcare strategies.
QNB Group is one of the leading financial institutions in the MEA region and among the most valuable banking brands in the regional market.
Present in over 28 countries across Asia, Europe, and Africa, it offers tailored products and services supported by innovation and backed by a team of over 31,000 professionals dedicated to driving banking excellence worldwide.
